Blood Pressure Medication Valsartan, Manufactured by Aurobindo, Recalled Over Cancer Concerns: FDA

Another manufacturer of valsartan announced on Dec. 31 that it’s recalling 80 lots of tablets due to a detection of a carcinogenic substance.

Aurobindo Pharma USA, Inc. said on the U.S. Food and Drug Administration’s (FDA) website that it’s voluntarily recalling Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP, and Valsartan Tablets USP at the consumer level.